Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Goldsmith

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Clinical Schizophrenia & Related Psychoses|June 27, 2018
Re-titration rates after clozapine-induced neutropenia or agranulocytosis: A case report and literature reviewMina Boazak, Benjamin Kahn, Lindsay Cox, et al.
Community Mental Health Journal|November 12, 2017
Characteristics of Medicaid Recipients Receiving Persistent Antipsychotic PolypharmacyRobert O Cotes, David R Goldsmith, Sarah L Kopelovich, et al.
Molecular Psychiatry|September 18, 2021
Transcriptomic signatures of psychomotor slowing in peripheral blood of depressed patients: evidence for immunometabolic reprogrammingMandakh Bekhbat, David R Goldsmith, Bobbi J Woolwine, et al.
Schizophrenia Research|March 4, 2018
TNF-α and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophreniaDavid R Goldsmith, Ebrahim Haroon, Andrew H Miller, et al.
International Journal of Obesity (2005)|August 15, 2025
Weight change from incretin-based weight loss medications across categories of second-generation antipsychoticsJithin Sam Varghese, David R Goldsmith, Robert O Cotes, et al.
Brain, Behavior, and Immunity|June 10, 2023
The human lncRNA GOMAFU suppresses neuronal interferon response pathways affected in neuropsychiatric diseasesPeng Teng, Yangping Li, Li Ku, et al.
Brain, Behavior, and Immunity|March 22, 2020
Gene signatures in peripheral blood immune cells related to insulin resistance and low tyrosine metabolism define a sub-type of depression with high CRP and anhedoniaMandakh Bekhbat, Michael T Treadway, David R Goldsmith, et al.
Pharmacological Reviews|July 21, 2021
Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological ImplicationsMichael J Lucido, Mandy Bekhbat, David R Goldsmith, et al.
Brain, Behavior, and Immunity|May 11, 2020
Protein and gene markers of metabolic dysfunction and inflammation together associate with functional connectivity in reward and motor circuits in depressionDavid R Goldsmith, Mandakh Bekhbat, Ngoc-Anh Le, et al.
Comprehensive Psychoneuroendocrinology|February 21, 2025
Lipids and C-reactive protein predict anhedonia and reward circuit functional connectivity responses to anti-cytokine and dopaminergic therapies in patients with depressionAditya Singh, Mandakh Bekhbat, David R Goldsmith, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Clinical Schizophrenia & Related Psychoses|June 27, 2018
Re-titration rates after clozapine-induced neutropenia or agranulocytosis: A case report and literature reviewMina Boazak, Benjamin Kahn, Lindsay Cox, et al.
Community Mental Health Journal|November 12, 2017
Characteristics of Medicaid Recipients Receiving Persistent Antipsychotic PolypharmacyRobert O Cotes, David R Goldsmith, Sarah L Kopelovich, et al.
Molecular Psychiatry|September 18, 2021
Transcriptomic signatures of psychomotor slowing in peripheral blood of depressed patients: evidence for immunometabolic reprogrammingMandakh Bekhbat, David R Goldsmith, Bobbi J Woolwine, et al.
Schizophrenia Research|March 4, 2018
TNF-α and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophreniaDavid R Goldsmith, Ebrahim Haroon, Andrew H Miller, et al.
International Journal of Obesity (2005)|August 15, 2025
Weight change from incretin-based weight loss medications across categories of second-generation antipsychoticsJithin Sam Varghese, David R Goldsmith, Robert O Cotes, et al.
Brain, Behavior, and Immunity|June 10, 2023
The human lncRNA GOMAFU suppresses neuronal interferon response pathways affected in neuropsychiatric diseasesPeng Teng, Yangping Li, Li Ku, et al.
Brain, Behavior, and Immunity|March 22, 2020
Gene signatures in peripheral blood immune cells related to insulin resistance and low tyrosine metabolism define a sub-type of depression with high CRP and anhedoniaMandakh Bekhbat, Michael T Treadway, David R Goldsmith, et al.
Pharmacological Reviews|July 21, 2021
Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological ImplicationsMichael J Lucido, Mandy Bekhbat, David R Goldsmith, et al.
Brain, Behavior, and Immunity|May 11, 2020
Protein and gene markers of metabolic dysfunction and inflammation together associate with functional connectivity in reward and motor circuits in depressionDavid R Goldsmith, Mandakh Bekhbat, Ngoc-Anh Le, et al.
Comprehensive Psychoneuroendocrinology|February 21, 2025
Lipids and C-reactive protein predict anhedonia and reward circuit functional connectivity responses to anti-cytokine and dopaminergic therapies in patients with depressionAditya Singh, Mandakh Bekhbat, David R Goldsmith, et al.
Pageof 8